IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival

European Journal of Cancer

Volumn 37, Issue 4, 2001, Pages 478-485

  Katsaros, D ^a   Yu, H ^b   Levesque, M A ^c   Danese, S ^a   Genta, F ^a   Richiardi, G ^a   Fracchioli, S ^a   Khosravi, M J ^d   Diamandi, A ^d   Gordini, G ^a   Diamandis, E P ^c   Massobrio, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Louisiana State University School of Medicine Shreveport   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d Diagnostic Systems Laboratories Canada Inc   (Canada)

Author keywords

IGFBP 3; Ovarian cancer; Prognosis; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; PACLITAXEL; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035082068     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00423-8     Document Type: Article

References (30)

1. Cancer statistics, 1998
2. Prognostic factors in ovarian cancer
3. Insulin-like growth factors and their binding proteins: Biological actions
4. Growth factors interact with estradiol and gonadotropins in the regulation of ovarian cancer cell growth and growth factor receptors
5. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-cL gene product
6. Molecular and cellular aspects of the insulin-like growth factor I receptor
7. Induction of the growth inhibitor IGF-binding protein 3 by p53
8. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action
9. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor b2-induced inhibition in human breast cancer cells
10. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3
11. Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer
12. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer
13. Immunohistochemical localization of insulin-like growth factor I receptors in benign and malignant tissues of the female genital tract
14. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer
15. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells
16. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: Correlation with cancer antigen 125 and tumor-associated trypsin inhibitor
17. Changes in definition of clinical staging for carcinoma of the cervix and ovary
18. WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy
19. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth
20. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
21. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts
22. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism
23. Insulin-like growth factor binding protein (IGFBP) proteases: Functional regulations of cell growth
24. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: Detection of higher levels in tumors with poor prognostic features
25. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: Correlation with clinical parameters and disease-free survival
26. Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer
27. Insulin-like growth factor binding protein-3 and breast cancer survival
28. IGF system components as prognostic markers in breast cancer
29. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: The relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation